The Downregulation of LSAMP Expression Promotes Lung Cancer Progression and Is Associated with Poor Survival Prognosis

Lung cancer has been a leading cause of cancer-related death for decades and therapeutic strategies for non-driver mutation lung cancer are still lacking. A novel approach for this type of lung cancer is an emergent requirement. Here we find that loss of LSAMP (Limbic System Associated Membrane Prot...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Pers Med
Hlavní autoři: Chang, Chao-Yuan, Wu, Kuan-Li, Chang, Yung-Yun, Liu, Yu-Wei, Huang, Yung-Chi, Jian, Shu-Fang, Lin, Yi-Shiuan, Tsai, Pei-Hsun, Hung, Jen-Yu, Tsai, Ying-Ming, Hsu, Ya-Ling
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8234324/
https://ncbi.nlm.nih.gov/pubmed/34202934
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11060578
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky